Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal acetazolamide spray for obstructive sleep apnea
IRCT20240526061903N3Phase 2Completed
- Sponsor
- Vice Chancellor for Research, Birjand University of Medical Sciences
- Start
- Jan 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of acetazolamide in obstructive sleep apnea hypopnea syndrome (OSAHS) (4 arms), sponsored by Vice Chancellor for Research, Birjand University of Medical Sciences. Primary endpoints: Sleep Quality Index, oxygen saturation and 1 more. Started Jan 2025; status: completed.
02
Drugs
acetazolamide
03
Conditions
obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on IRCT20240526061903N3.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240526061903N3.